Bristol-Myers Surrenders Anti-HIV Drug Patent In Thailand

Law360, New York (January 16, 2004, 12:00 AM EST) -- Bristol-Myers Squibb has given up a long-standing patent dispute with Thai AIDS activists and agreed to surrender its patent for the anti-retroviral drug didanosine (ddI) in tablet form.

Didanosine is used in combination with other drugs in an ARV "AIDS cocktail" used to treat HIV. Ddi has been produced in Thailand in powdered form for years, mainly by the Government Pharmaceutical Organization (GPO), but the tablets are more convenient and reliable and will now be cheaper.

The patent was granted by Thailand's Department of Intellectual Properties...
To view the full article, register now.